Literature DB >> 31110052

Therapeutic Potential of Newer Drugs for Treating Hyperkalemia.

Matthew R Weir1.   

Abstract

Entities:  

Keywords:  Potassium; chronic kidney disease; hyperkalemia; renin angiotensin aldosterone-system inhibitors; risk factors

Mesh：

Substances：

Year:  2019        PMID： 31110052      PMCID： PMC6556732          DOI： 10.2215/CJN.04750419

Source DB:  PubMed          Journal:  Clin J Am Soc Nephrol        ISSN： 1555-9041            Impact factor:   8.237


× No keyword cloud information.
  10 in total

1.  Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes.

Authors:  E J Lewis; L G Hunsicker; W R Clarke; T Berl; M A Pohl; J B Lewis; E Ritz; R C Atkins; R Rohde; I Raz
Journal:  N Engl J Med       Date:  2001-09-20       Impact factor: 91.245

2.  Sodium Zirconium Cyclosilicate among Individuals with Hyperkalemia: A 12-Month Phase 3 Study.

Authors:  Bruce S Spinowitz; Steven Fishbane; Pablo E Pergola; Simon D Roger; Edgar V Lerma; Javed Butler; Stephan von Haehling; Scott H Adler; June Zhao; Bhupinder Singh; Philip T Lavin; Peter A McCullough; Mikhail Kosiborod; David K Packham
Journal:  Clin J Am Soc Nephrol       Date:  2019-05-20       Impact factor: 8.237

3.  Dietary potassium intake and mortality in long-term hemodialysis patients.

Authors:  Nazanin Noori; Kamyar Kalantar-Zadeh; Csaba P Kovesdy; Sameer B Murali; Rachelle Bross; Allen R Nissenson; Joel D Kopple
Journal:  Am J Kidney Dis       Date:  2010-06-30       Impact factor: 8.860

4.  Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy.

Authors:  B M Brenner; M E Cooper; D de Zeeuw; W F Keane; W E Mitch; H H Parving; G Remuzzi; S M Snapinn; Z Zhang; S Shahinfar
Journal:  N Engl J Med       Date:  2001-09-20       Impact factor: 91.245

5.  The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators.

Authors:  B Pitt; F Zannad; W J Remme; R Cody; A Castaigne; A Perez; J Palensky; J Wittes
Journal:  N Engl J Med       Date:  1999-09-02       Impact factor: 91.245

6.  Patiromer in patients with kidney disease and hyperkalemia receiving RAAS inhibitors.

Authors:  Matthew R Weir; George L Bakris; David A Bushinsky; Martha R Mayo; Dahlia Garza; Yuri Stasiv; Janet Wittes; Heidi Christ-Schmidt; Lance Berman; Bertram Pitt
Journal:  N Engl J Med       Date:  2014-11-21       Impact factor: 91.245

Review 7.  Gastrointestinal adverse events with sodium polystyrene sulfonate (Kayexalate) use: a systematic review.

Authors:  Ziv Harel; Shai Harel; Prakesh S Shah; Ron Wald; Jeffrey Perl; Chaim M Bell
Journal:  Am J Med       Date:  2013-01-12       Impact factor: 4.965

8.  Incidence, predictors, and outcomes related to hypo- and hyperkalemia in patients with severe heart failure treated with a mineralocorticoid receptor antagonist.

Authors:  Orly Vardeny; Brian Claggett; Inder Anand; Patrick Rossignol; Akshay S Desai; Faiez Zannad; Bertram Pitt; Scott D Solomon
Journal:  Circ Heart Fail       Date:  2014-05-08       Impact factor: 8.790

9.  The frequency of hyperkalemia and its significance in chronic kidney disease.

Authors:  Lisa M Einhorn; Min Zhan; Van Doren Hsu; Lori D Walker; Maureen F Moen; Stephen L Seliger; Matthew R Weir; Jeffrey C Fink
Journal:  Arch Intern Med       Date:  2009-06-22

10.  Evaluation of the efficacy and safety of RLY5016, a polymeric potassium binder, in a double-blind, placebo-controlled study in patients with chronic heart failure (the PEARL-HF) trial.

Authors:  Bertram Pitt; Stefan D Anker; David A Bushinsky; Dalane W Kitzman; Faiez Zannad; I-Zu Huang
Journal:  Eur Heart J       Date:  2011-01-05       Impact factor: 29.983
  10 in total
  1 in total

1.  Efficacy and safety of sodium zirconium cyclosilicate for hyperkalaemia: the randomized, placebo-controlled HARMONIZE-Global study.

Authors:  Faiez Zannad; Bang-Gee Hsu; Yoshitaka Maeda; Sug Kyun Shin; Elena M Vishneva; Martin Rensfeldt; Stefan Eklund; June Zhao
Journal:  ESC Heart Fail       Date:  2020-01-15
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.